The global sepsis diagnostics market is anticipated to grow at a significant CAGR during the forecast period. Sepsis is amongst one of the severe diseases and emerges as a leading cause of fatality globally. It occurs when chemicals released in the bloodstream to fight an infection generates inflammation throughout the body. Some of the symptoms include fever, difficulty in breathing, low BP, rapid heart rate, and mental confusion. However, early diagnosis of the disease can enhance the conditions and even contributes to market growth.

Get Free Sample Copy @https://www.omrglobal.com/request-sample/lysosomal-storage-disease-market

The primary factors that propel the growth of the market include increased incidences of sepsis, the introduction of technologically advanced diagnostic solutions along with increased awareness among the peoples. As per WHO, sepsis is one of the life-threatening diseases, and it affects approximately 30 million people across the globe and causes around 6 million deaths every year. Every year approximately 1.2 million children and 3 million infants suffer from sepsis across the globe. Thus, the increased incidences of sepsis are likely to create scope for market growth during the forecast period.

Browse for Full Report Description@https://www.omrglobal.com/industry-reports/lysosomal-storage-disease-market

Moreover, in the geriatric population, newborn babies, and people suffering from chronic disease, there are increased chances of hospital-acquired infections (HAIs) which may cause sepsis. AS per CDC, in the US alone, approximately 1.7 million patients suffer from HAIs, in which approximately 99,000 patients die due to HAIs. Thus, the increased incidences and prevalence of HAIs are also likely to propel the market growth during the forecast period.

In June 2018 Sepsis Alliance, a non-profit organization involved “It's About Time”, a nationwide initiative to create awareness regarding rapid diagnosis and treatment of the sepsis. Such initiatives by the organizations are intended to raise awareness about the disease and encourage the demand for its diagnostic solutions. Thus, it is estimated to create ample opportunities for the growth of the market.

Market Segmentation

Global Sepsis Diagnostics Market by Product Type

Instruments
Assays and Reagents
Others
Global Sepsis Diagnostics Market by Technology

Molecular Diagnostics
Immunoassay
Others (Flow Cytometry)
Global Sepsis Diagnostics Market by Pathogen

Bacterial Sepsis Diagnostics
Fungal Sepsis Diagnostics
Others
Regional Analysis

North America

United States
Canada
Europe

UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific

China
India
Japan
Rest of Asia-Pacific
Rest of the World

Company Profiles

Abbott Laboratories, Inc.
Abionic SA
Accelerate Diagnostics, Inc.
Becton, Dickinson & Co.
Biomérieux SA
Bruker Corp.
Cepheid Inc.
Danaher Corp.
EKF Diagnostics Holdings plc
F. Hoffmann-La Roche Ltd.
Immunexpress Inc.
Inflammatix, Inc.
Luminex Corp.
Nan?mix, Inc.
Qiagen NV
Quidel Corp.
Seegene Inc.
Siemens AG
Sysmex Corp.
T2 Biosystems, Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech Plc
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lysosomal-storage-disease-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404